Mandel-Brehm Josh 4
4 · ProMIS Neurosciences Inc. · Filed Oct 7, 2024
Insider Transaction Report
Form 4
Mandel-Brehm Josh
Director
Transactions
- Award
Option (right to buy)
2024-10-03+40,000→ 40,000 totalExercise: $1.11Exp: 2034-10-03→ Common Shares (40,000 underlying)
Footnotes (1)
- [F1]33% of the shares subject to this option vested on October 3, 2024, and the balance shall vest ratably over the following 24 months, subject to the Reporting Person's continued service on each such vesting date.